JP3115374B2 - Patient monitoring system - Google Patents

Patient monitoring system

Info

Publication number
JP3115374B2
JP3115374B2 JP03264039A JP26403991A JP3115374B2 JP 3115374 B2 JP3115374 B2 JP 3115374B2 JP 03264039 A JP03264039 A JP 03264039A JP 26403991 A JP26403991 A JP 26403991A JP 3115374 B2 JP3115374 B2 JP 3115374B2
Authority
JP
Japan
Prior art keywords
oxygen saturation
cardiac output
blood
oxygen
continuously
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP03264039A
Other languages
Japanese (ja)
Other versions
JPH0595939A (en
Inventor
弘昌 河野
重和 関位
耕二 土田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP03264039A priority Critical patent/JP3115374B2/en
Publication of JPH0595939A publication Critical patent/JPH0595939A/en
Application granted granted Critical
Publication of JP3115374B2 publication Critical patent/JP3115374B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、病院等の医療施設に於
ける手術室,ICU等において、患者の酸素需給バラン
スや循環動態の把握に有用な患者監視システムに関する
ものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a patient monitoring system useful for grasping the oxygen supply / demand balance and circulatory dynamics of a patient in an operating room, an ICU or the like in a medical facility such as a hospital.

【0002】[0002]

【従来の技術】従来、心機能検査のために右心カテーテ
ル法によって心拍出量を測定するには指示薬希釈法が用
いられており、この指示薬希釈法には熱拡散から心拍出
量を求める熱希釈法、色素拡散による照度の変化から心
拍出量を求める色素希釈法がある。近年では、熱希釈法
により求めた心拍出量と熱式領流量測定により求めた連
続的な血流速度とから連続的に心拍出量の測定が行える
心拍出量測定装置(例えば、特開昭61−125329
号公報など)も報告されている。
2. Description of the Related Art Conventionally, an indicator dilution method has been used to measure cardiac output by a right heart catheterization method for a cardiac function test. In this indicator dilution method, the cardiac output is measured by heat diffusion. There are a thermodilution method and a dye dilution method for obtaining a cardiac output from a change in illuminance due to dye diffusion. In recent years, a cardiac output measurement device capable of continuously measuring cardiac output from a cardiac output obtained by a thermodilution method and a continuous blood flow velocity obtained by a thermal flow measurement (for example, JP-A-61-125329
Publications).

【0003】また、血液の吸光(反射)特性を利用した
酸素飽和度モニタが一般に広まってきており、右心カテ
ーテルに光ファイバーを組み込んだ、混合静脈血酸素飽
和度(SvO2 )測定を行なう装置も開発されてきてい
る。
In addition, oxygen saturation monitors utilizing the absorption (reflection) characteristics of blood have become widespread, and there is also an apparatus for measuring mixed venous oxygen saturation (SvO 2 ) incorporating an optical fiber in a right heart catheter. Is being developed.

【0004】[0004]

【発明が解決しようとしている課題】心拍出量は心機能
評価において有用なパラメータであるが、しかしながら
それだけでは、循環,呼吸,代謝のバランス、言い替え
ると、酸素の需給バランスを総合的に判断することはで
きない。一方、混合静脈血酸素飽和度値は、循環の指標
である心拍出量、呼吸の指標である動脈血酸素飽和度、
および代謝の指標である酸素消費量のどれにも影響され
る複合パラメータであり、その値だけでは患者の病態把
握は難しいと考えられる。
The cardiac output is a useful parameter in the evaluation of cardiac function. However, it alone determines the balance of circulation, respiration and metabolism, in other words, the overall balance of oxygen supply and demand. It is not possible. On the other hand, the mixed venous oxygen saturation value is a cardiac output which is an index of circulation, an arterial oxygen saturation which is an index of respiration,
It is a complex parameter that is influenced by any of oxygen consumption, which is an indicator of metabolism, and it is considered that it is difficult to grasp the patient's condition only by its value.

【0005】本発明は、上記従来例を鑑みてなされたも
ので、酸素の需給バランスをより確実に把握でき、術
中,術後の患者管理に有用な患者監視システムを提供す
ることを目的としている。
The present invention has been made in view of the above conventional example, and has as its object to provide a patient monitoring system that can more reliably grasp the supply and demand balance of oxygen and is useful for intraoperative and postoperative patient management. .

【0006】[0006]

【課題を解決するための手段】上記目的を達成するため
に、本発明の患者監視システムは、混合静脈血の酸素飽
和度値を連続的に測定する酸素飽和度測定手段と、連続
的に心拍出量を測定する心拍出量測定手段と、動脈血酸
素飽和度値とヘモグロビン濃度とを入力するパラメータ
入力手段と、前記酸素飽和度測定手段により求められた
混合静脈血の前記酸素飽和度値と、前記心拍出量測定手
段により求められた前記心拍出量値と、前記パラメータ
入力手段により入力された前記動脈血酸素飽和度値及び
ヘモグロビン濃度とから連続的に酸素消費量を算出する
酸素消費量算出手段とを備える。更に、前記酸素飽和度
測定手段により求められた混合静脈血の前記酸素飽和度
値と、前記パラメータ入力手段により入力された前記動
脈血酸素飽和度値とから連続的に酸素摂取率を算出する
酸素摂取率算出手段を備える。
In order to achieve the above object, a patient monitoring system according to the present invention comprises: an oxygen saturation measuring means for continuously measuring the oxygen saturation value of mixed venous blood; Cardiac output measuring means for measuring the output, parameter input means for inputting arterial blood oxygen saturation value and hemoglobin concentration, and the oxygen saturation value of mixed venous blood obtained by the oxygen saturation measuring means Oxygen for continuously calculating oxygen consumption from the cardiac output value obtained by the cardiac output measuring means, and the arterial oxygen saturation value and hemoglobin concentration input by the parameter input means. A consumption calculating means. Further, the oxygen uptake for continuously calculating the oxygen uptake rate from the oxygen saturation value of the mixed venous blood obtained by the oxygen saturation measuring means and the arterial blood oxygen saturation value inputted by the parameter input means. It has a rate calculating means.

【0007】ここで、酸素飽和度測定手段は2つの異な
る波長の光の血液への照射に対する反射光強度の比に基
づいて連続的に血液の酸素飽和度を測定する。また、心
拍出量測定手段は校正時の血液温度,平衡温度及び熱希
釈法により求めた心拍出量に基づいて、測定時の血液温
度と平衡温度とから連続的に心拍出量を測定する。
Here, the oxygen saturation measuring means continuously measures the oxygen saturation of the blood based on the ratio of the intensity of the reflected light with respect to the irradiation of the blood with light of two different wavelengths. The cardiac output measuring means continuously calculates the cardiac output from the blood temperature and the equilibrium temperature at the time of measurement, based on the blood temperature at the time of calibration, the equilibrium temperature, and the cardiac output obtained by the thermodilution method. Measure.

【0008】更に、前記酸素飽和度測定手段と前記心拍
出量測定手段とに必要な信号を検出して供給する単一の
プローブを備える。
[0008] Further, a single probe is provided for detecting and supplying necessary signals to the oxygen saturation measuring means and the cardiac output measuring means.

【0009】[0009]

【作用】以上の構成において、連続測定した心拍出量と
混合静脈血酸素飽和度値、およびモニタ開始時または定
期的に、または連続的に装置に入力されるヘモグロビン
濃度と動脈血酸素飽和度値から、酸素消費量や酸素摂取
率が計算され、心拍出量および混合静脈酸素飽和度値と
合わせ、連続的に酸素消費量と酸素摂取率とが監視され
るようにしたものである。
In the above configuration, the continuously measured cardiac output and the mixed venous oxygen saturation value, and the hemoglobin concentration and the arterial oxygen saturation value input to the apparatus at the start of monitoring or periodically or continuously. , The oxygen consumption and the oxygen uptake rate are calculated, and are combined with the cardiac output and the mixed venous oxygen saturation value to continuously monitor the oxygen consumption and the oxygen uptake rate.

【0010】[0010]

【実施例】以下、添付図面を参照して本発明に関わる好
適な一実施例を詳細に説明する。 <システム構成>図1は本実施例の患者監視システム1
の構成を示すブロック図である。本実施例の患者監視シ
ステム1は基本的には、酸素消費量を算出する酸素消費
量演算部10と、心拍出量(以下CCOMともいう)を
算出する心拍出量モニタ部20と、酸素飽和度(以下C
OSMともいう)を算出する酸素飽和度モニタ部30
と、電源部40と、プローブ50とから構成されてい
る。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS A preferred embodiment according to the present invention will be described below in detail with reference to the accompanying drawings. <System Configuration> FIG. 1 shows a patient monitoring system 1 of the present embodiment.
FIG. 3 is a block diagram showing the configuration of FIG. The patient monitoring system 1 of the present embodiment basically includes an oxygen consumption calculating unit 10 for calculating oxygen consumption, a cardiac output monitoring unit 20 for calculating cardiac output (hereinafter also referred to as CCOM), Oxygen saturation (hereinafter C
Oxygen saturation monitor 30 for calculating OSM)
, A power supply unit 40, and a probe 50.

【0011】酸素消費量演算部10は、システム全体を
制御するメインCPU回路11と、メインCPU回路1
1の制御手順を格納するROM12と、ヘモグロビン濃
度記憶部13a及び動脈血酸素飽和度記憶部13bを含
む補助記憶用のRAM13と、システムの操作キーある
いはヘモグロビン濃度や動脈血酸素飽和度を入力する入
力操作部14と、監視情報等を表示する表示部15と、
システム外へのデータのアナログ出力を実現するD/A
変換及びアナログ出力部16と、システム外部へのデジ
タル出力を実現するRS−232C等のデジタル出力部
17とを有する。
An oxygen consumption calculator 10 includes a main CPU circuit 11 for controlling the entire system, and a main CPU circuit 1
1 for storing a control procedure, a RAM 13 for auxiliary storage including a hemoglobin concentration storage unit 13a and an arterial oxygen saturation storage unit 13b, and an operation key for inputting system operation keys or hemoglobin concentration and arterial blood oxygen saturation. 14, a display unit 15 for displaying monitoring information and the like,
D / A that realizes analog output of data outside the system
It has a conversion and analog output section 16 and a digital output section 17 such as RS-232C for realizing digital output to the outside of the system.

【0012】心拍出量モニタ部20は、後で詳細に説明
するが、基本的には人体に設置されたプローブからの必
要なデータを入力処理するCCOM計測部21とCCO
M計測部21からのデータに基づいて心拍出量を算出す
るCCOM演算部22とから成る。
As will be described later in detail, the cardiac output monitoring unit 20 is basically composed of a CCOM measuring unit 21 for input processing of necessary data from a probe installed on a human body and a CCO measuring unit 21.
A CCOM operation unit 22 for calculating the cardiac output based on the data from the M measurement unit 21.

【0013】酸素飽和度モニタ部30は、後で詳細に説
明するが、基本的には人体に設置されたプローブからの
必要なデータを入力処理するCOSM計測部31とCO
SM計測部31からのデータに基づいて酸素飽和度を算
出するCOSM演算部22とから成る。
As will be described later in detail, the oxygen saturation monitoring unit 30 basically includes a COSM measuring unit 31 and a COSM measuring unit 31 for inputting necessary data from a probe installed on a human body.
A COSM operation unit 22 that calculates oxygen saturation based on data from the SM measurement unit 31.

【0014】電源部40は、商用電源からの電源ノイズ
を減衰させるためのラインフイルタ41とシステム内の
各種電源を作成して前記各部に供給するスイツチング・
レギユレータを有する電源回路42から成る。
A power supply section 40 is a line filter 41 for attenuating power supply noise from a commercial power supply, and a switching / supplying section for creating various power supplies in the system and supplying the power supplies to the respective sections.
The power supply circuit 42 has a regulator.

【0015】プローブ50は図5に詳細に示されている
ように単一のプローブであり、本システムに必要な全て
のデータの収集が可能である。
The probe 50 is a single probe, as shown in detail in FIG. 5, and can collect all the data required for the system.

【0016】尚、本システムでは各制御部が独立に非同
期で動作するようクロツクは独立しているが、メインC
PU回路11からのクロツクに全ての制御を同期させる
ようにしてもよい。
In this system, the clocks are independent so that each control unit operates independently and asynchronously.
All controls may be synchronized with the clock from the PU circuit 11.

【0017】<動作手順>図2はメインCPU回路11
の制御手順を示すフローチヤートである。
<Operation Procedure> FIG.
5 is a flowchart showing a control procedure of the first embodiment.

【0018】まず、ステツプS21で数値(ヘモグロビ
ン濃度あるいは動脈血酸素飽和度)の入力か否か、ステ
ツプS25で酸素消費量(および/または酸素摂取率)
のモニタ表示か否かを判定する。どちらの処理でもない
場合は、ステツプS21,S25をループする。
First, in step S21, whether a numerical value (hemoglobin concentration or arterial oxygen saturation) is input or not, in step S25, oxygen consumption (and / or oxygen intake rate).
It is determined whether or not the monitor display is performed. If neither of the processes is performed, the process loops steps S21 and S25.

【0019】数値入力の場合は、ステツプS22でどち
らの値の入力かを判断し、ヘモグロビン濃度の場合はス
テツプS23で入力値をヘモグロビン濃度記憶部13a
に記憶し、動脈血酸素飽和度の場合はステツプS24で
動脈血酸素飽和度記憶部13bに記憶する。
In the case of a numerical value input, it is determined in step S22 which value is to be input. In the case of a hemoglobin concentration, the input value is determined in step S23 in the hemoglobin concentration storage unit 13a.
In the case of the arterial blood oxygen saturation, it is stored in the arterial blood oxygen saturation storage unit 13b in step S24.

【0020】一方、酸素消費量のモニタ表示の場合は、
ステツプS26に進んで、酸素飽和度モニタ部30から
混合静脈血酸素飽和度を受信し、ステツプS27で心拍
出量モニタ部40から心拍出量を受信する。ステツプS
28で受信した混合静脈血酸素飽和度及び心拍出量と、
予め入力されて記憶されているヘモグロビン濃度及び動
脈血酸素飽和度とから酸素消費量を算出する。
On the other hand, in the case of the monitor display of the oxygen consumption,
Proceeding to step S26, the mixed venous blood oxygen saturation is received from the oxygen saturation monitor 30, and the cardiac output is received from the cardiac output monitor 40 in step S27. Step S
Mixed venous oxygen saturation and cardiac output received at 28;
The oxygen consumption is calculated from the hemoglobin concentration and the arterial oxygen saturation previously input and stored.

【0021】ここで、酸素消費量の算出方法について説
明する。以下に示すように、酸素消費量(VO2 ),動
脈血酸素含量(CaC2 ),混合静脈血酸素含量(Cv
2)、および心拍出量(CO)との間に成立する関係
式として、Fickの式がある。
Here, a method of calculating the oxygen consumption will be described. As shown below, oxygen consumption (VO 2 ), arterial blood oxygen content (CaC 2 ), mixed venous blood oxygen content (Cv
O 2 ) and the cardiac output (CO) include the Fick equation.

【0022】 VO2 =(CaO2 −CvO2 )×CO …[1] 一方、酸素含量は、次式のように、ヘモグロビン濃度
(Hb),酸素飽和度(SxO2 )および酸素分圧(P
xO2 )とで表わされ(ここでxはa〜z)、 CaO2 =1.34×Hb×SaO2 +0.0031×PaO2 …[2] CvO2 =1.34×Hb×SvO2 +0.0031×PvO2 …[3] [2]および[3]式の第2項は極めて小さく無視でき
るので、[1]式は次式のようになる。
VO 2 = (CaO 2 −CvO 2 ) × CO (1) On the other hand, the oxygen content is represented by the following formula, hemoglobin concentration (Hb), oxygen saturation (SxO 2 ), and oxygen partial pressure (P
xO 2 ) (where x is a to z), CaO 2 = 1.34 × Hb × SaO 2 + 0.0031 × PaO 2 ... [2] CvO 2 = 1.34 × Hb × SvO 2 + 0.0031 × PvO 2 [3] Since the second term of the equations [2] and [3] is extremely small and can be ignored, the equation [1] is as follows.

【0023】 VO2 =1.34×Hb×(SaO2 −SvO2 )×CO …[4] [4]式より、酸素消費量(VO2 )は、ヘモグロビン
濃度(Hb)と動脈血酸素飽和度(SaO2 )と混合静
脈血酸素飽和度(SvO2 )と心拍出量(CO)とから
算出される。酸素消費量が算出できれば、酸素摂取率も
算出できるのは自明である。
VO 2 = 1.34 × Hb × (SaO 2 −SvO 2 ) × CO [4] From equation [4], the oxygen consumption (VO 2 ) is represented by the hemoglobin concentration (Hb) and the arterial oxygen saturation. (SaO 2 ), mixed venous oxygen saturation (SvO 2 ), and cardiac output (CO). Obviously, if the oxygen consumption can be calculated, the oxygen uptake rate can also be calculated.

【0024】ステツプS29で、酸素消費量以下酸素摂
取率あるいは測定された混合静脈血酸素飽和度,心拍出
量等を必要に応じてフオーマツト処理して表示器15に
表示する。
In step S29, the oxygen uptake rate below the oxygen consumption or the measured mixed venous oxygen saturation, cardiac output, etc. are subjected to format processing as necessary and displayed on the display unit 15.

【0025】<心拍出量モニタ部の構成例>図3は心拍
出量モニタ部の一構成例のブロツク図である。
<Example of Configuration of Cardiac Output Monitor> FIG. 3 is a block diagram of an example of the configuration of the cardiac output monitor.

【0026】図3において、20は心拍出量モニタ部の
本体であり、外部に交換自在型の心拍出量測定用カテー
テル102及び107を接続する。カテーテル102
は、熱希釈法に基づく指示薬注入用及び指示薬温度検出
用カテーテルであり、内部には指示薬温度を検出する感
温素子103、及び前記感温素子の特性のバラツキを補
正する補正抵抗器104から成る指示薬検温プローブ回
路115を備える。そして、この指示薬検温プローブ回
路115はコネクタ105及び106を介して心拍出量
モニタ部本体の計測部21の注入液温度計測回路124
に電気的に接続され、心拍出量測定の際は心臓の右心房
に位置する。
In FIG. 3, reference numeral 20 denotes a main body of a cardiac output monitor section, to which externally exchangeable cardiac output measuring catheters 102 and 107 are connected. Catheter 102
Is a catheter for injecting an indicator and detecting an indicator temperature based on a thermodilution method, and comprises a temperature-sensitive element 103 for detecting the indicator temperature and a correction resistor 104 for correcting variations in the characteristics of the temperature-sensitive element. An indicator temperature probe circuit 115 is provided. The indicator temperature detection probe circuit 115 is connected to the infusion liquid temperature measurement circuit 124 of the measurement unit 21 of the cardiac output monitor unit via connectors 105 and 106.
And is located in the right atrium of the heart when measuring cardiac output.

【0027】カテーテル107は、血液の温度を検出し
たり、定電流源回路123からの一定電流によつて加温
され血流によつて冷却される感温素子の温度(以下、平
衡温度と呼ぶ)を検出する血液温度・平衡温度検出用カ
テーテルであり、内部には右心房、及び右心室で熱希釈
された血液温度を検出するサーミスタ108と前記サー
ミスタの特性を補正する補正抵抗器109から成る血液
検温プローブ回路116、そして熱式流量測定法により
血流速変化を平衡温度として検出するサーミスタ110
(好ましくは自己加温型サーミスタ)から成る平衡温度
検温プローブ回路117を備える。
The catheter 107 detects the temperature of the blood, and is heated by a constant current from the constant current source circuit 123 and cooled by the blood flow (hereinafter referred to as an equilibrium temperature). ) Is a catheter for detecting blood temperature and equilibrium temperature, and comprises a thermistor 108 for detecting the temperature of blood thermally diluted in the right atrium and right ventricle, and a correction resistor 109 for correcting the characteristics of the thermistor. Blood temperature probe circuit 116 and thermistor 110 for detecting a change in blood flow velocity as an equilibrium temperature by a thermal flow measurement method
An equilibrium temperature detection probe circuit 117 composed of (preferably a self-heating thermistor) is provided.

【0028】血液検温プローブ回路116及び平衡温度
検温プローブ回路117は、コネクタ111及び112
を介して、それぞれ心拍出量モニタ部本体の計測部21
の血液温度計測回路125と平衡温度計測回路126に
電気的に接続され、心拍出量測定の際は肺動脈に位置
し、中枢部の体温を血液温度信号として検出する。
The blood temperature probe circuit 116 and the equilibrium temperature probe circuit 117 include connectors 111 and 112, respectively.
Via the measuring unit 21 of the main body of the cardiac output monitor unit
Is electrically connected to the blood temperature measurement circuit 125 and the equilibrium temperature measurement circuit 126, and is located in the pulmonary artery at the time of cardiac output measurement, and detects the central body temperature as a blood temperature signal.

【0029】次に、心拍出量モニタ部の動作を説明す
る。
Next, the operation of the cardiac output monitor will be described.

【0030】心拍出量モニタ部20は、機能の面から以
下の如く分けられる。即ち、カテーテル102及び10
7を介して各種温度計測を実行する計測部21と、計測
部21で計測した測定データ等を光学的手段により伝送
するオプトアイソレーシヨン通信回路135と、オプト
アイソレーシヨン通信回路135を介して入力した測定
データに基づいて熱希釈法により間欠的に、あるいは平
衡温度測定により連続的に心拍出量を演算し出力するメ
インCPU部22と、前記メインCPU部22が演算し
て求めた心拍出量値を外部に出力する外部出力回路15
1とに分けられる。
The cardiac output monitor 20 is divided as follows in terms of functions. That is, catheters 102 and 10
7, a measurement unit 21 that executes various temperature measurements, an opto-isolation communication circuit 135 that transmits measurement data and the like measured by the measurement unit 21 by optical means, and an opto-isolation communication circuit 135. A main CPU unit 22 for calculating and outputting the cardiac output intermittently by thermodilution method based on the input measurement data or continuously by equilibrium temperature measurement, and a heart calculated by the main CPU unit 22 An external output circuit 15 for outputting a stroke volume value to the outside
It is divided into 1.

【0031】計測部21において、注入液温度計測回路
124はカテーテル102の開口部から右心房に吐出す
る指示薬温度を検出し、その温度に対応する電圧信号を
出力する。また、血液温度計測回路125は肺動脈にお
いて血液温度を検出して、対応する電圧信号を出力し、
平衡温度計測回路126は、例えば自己加温型のサーミ
スタに加えた熱量と周囲の血液の流速によつて奪われる
熱量との関係から平衡温度を検出し、対応する電圧信号
を出力する。
In the measuring section 21, the infusate temperature measuring circuit 124 detects the temperature of the indicator discharged from the opening of the catheter 102 into the right atrium, and outputs a voltage signal corresponding to the detected temperature. The blood temperature measurement circuit 125 detects the blood temperature in the pulmonary artery and outputs a corresponding voltage signal,
The equilibrium temperature measuring circuit 126 detects the equilibrium temperature from the relation between the amount of heat applied to the self-heating type thermistor and the amount of heat taken off by the flow rate of the surrounding blood, and outputs a corresponding voltage signal.

【0032】メインCPU144はローカルCPU13
0に対して、ROM145に格納されたプログラムに従
い前記各計測回路(注入液温度計測回路124、血液温
度計測回路125、平衡温度計測回路126)に計測の
実行を指示し、計測動作を制御する信号を送る。RAM
146には制御に必要なデータを一時的に格納する。こ
れらの信号は、後述する伝送形式にてオプトアイソレー
シヨン通信回路を介して伝えられる。また、ローカルC
PU130は前記各計測回路からの計測データを選択す
るために、アナログスイツチ127に選択信号を送る。
その結果、各計測回路からの計測データはアナログスイ
ツチを介してA/D変換器128に達し、そこでデジタ
ルデータに変換された後ローカルCPU130に取り込
まれる。そして、ローカルCPU130は、ROM12
9に格納されたプログラムに従い、自己の有するシリア
ル通信機能により受信データをシリアルデータとしてオ
プトアイソレーシヨン通信回路135に送る。
The main CPU 144 is the local CPU 13
0, a signal for instructing each of the measuring circuits (the infusate temperature measuring circuit 124, the blood temperature measuring circuit 125, and the equilibrium temperature measuring circuit 126) to execute the measurement according to the program stored in the ROM 145, and controlling the measurement operation. Send. RAM
146 temporarily stores data necessary for control. These signals are transmitted via an opto-isolation communication circuit in a transmission format described later. Also, local C
The PU 130 sends a selection signal to the analog switch 127 to select the measurement data from each of the measurement circuits.
As a result, the measurement data from each measurement circuit reaches the A / D converter 128 via the analog switch, where it is converted into digital data and then taken into the local CPU 130. Then, the local CPU 130
In accordance with the program stored in 9, the received data is sent to the opto-isolation communication circuit 135 as serial data by its own serial communication function.

【0033】オプトアイソレーシヨン通信回路135
は、計測部21とメインCPU部22間のデータの送受
信を電気的に完全に絶縁した状態で行ない、計測部21
側及びメインCPU144側それぞれに、フオトダイオ
ード回路及びフオトトランジスタ回路から成る光送受信
回路136,137と、前記光送受信回路を互いに電気
的に絶縁させ、両者の信号伝達媒体となる光フアイバグ
ラス138とで構成される。従つて、計測部20の電圧
信号とメインCPU部22の電圧信号との電気的接続は
完全に遮断され、被験者人体とメインCPU側とは如何
なる閉ループも形成されることがないので、安全な計測
が行なえる。
Opto-isolation communication circuit 135
Performs transmission and reception of data between the measurement unit 21 and the main CPU unit 22 in a state of being completely electrically insulated.
The optical transmission / reception circuits 136 and 137 each composed of a photodiode circuit and a phototransistor circuit, and the optical fiber glass 138 which electrically insulates the optical transmission / reception circuits from each other and serves as a signal transmission medium between them. Be composed. Therefore, the electrical connection between the voltage signal of the measuring section 20 and the voltage signal of the main CPU section 22 is completely cut off, and no closed loop is formed between the human body and the main CPU side. Can be done.

【0034】次に、メインCPU部22の動作を説明す
る。オプトアイソレーシヨン通信回路135からのシリ
アルデータは、メインCPU144にて受信される。心
拍出量校正手段141は、心拍出量の校正が熱希釈法に
よつて行なわれる場合を例にとると、冷却された、ある
いは暖められた注入液の注入によつて生じる血液の温度
変化を計測する前記血液温度計測回路125から、熱希
釈された血液温度に関する信号をメインCPU144か
ら受け取る。同時に心拍出量校正手段141は、スチユ
ワート・ハミルトンの式に基づいて注入液温度、注入液
比熱、注入液比重、血液比重、血液比熱、及び熱希釈さ
れた血液温度から熱希釈心拍出量を演算し、結果を校正
時心拍出量信号として校正時信号記憶手段142に出力
する。尚、重篤な患者で熱希釈法による指示薬の注入が
行なえない場合には、サムホイールスイツチやデジタル
スイツチ等の設定スイツチ、並びにキーボードより成る
心拍出量入力手段150により相応の心拍出量の値が入
力され、校正時の心拍出量値として校正時信号記憶手段
142に出力するという方法を採る。
Next, the operation of the main CPU section 22 will be described. Serial data from the opto-isolation communication circuit 135 is received by the main CPU 144. In a case where the cardiac output is calibrated by the thermodilution method, the cardiac output calibrating means 141 measures the temperature of blood caused by the injection of a cooled or warmed infusate. From the blood temperature measurement circuit 125 for measuring a change, a signal relating to the thermodiluted blood temperature is received from the main CPU 144. At the same time, the cardiac output calibrating means 141 calculates the thermodiluted cardiac output from the infusate temperature, the infusate specific heat, the infusate specific gravity, the blood specific gravity, the blood specific heat, and the thermodiluted blood temperature based on the Stuart-Hamilton equation. And outputs the result to the calibration signal storage means 142 as a calibration cardiac output signal. In addition, when the injection of the indicator by the thermodilution method cannot be performed in a serious patient, the corresponding cardiac output is set by a setting switch such as a thumbwheel switch or a digital switch, and a cardiac output input means 150 including a keyboard. Is input and output to the calibration signal storage means 142 as the cardiac output value at the time of calibration.

【0035】校正時信号記憶手段142は、熱希釈法に
よる心拍出量値、あるいは前記心拍出量入力手段150
によつて入力された心拍出量値を校正時心拍出量として
記憶保持すると共に、血液温度計測回路125からの血
液温度信号と平衡温度計測回路126からの平衡温度信
号を、それぞれ校正時血液温度、校正時平衡温度として
保持記憶する。そして、連続心拍出量演算手段143か
ら要求があつた場合、記憶保持したデータを出力する。
The calibration signal storage means 142 stores the cardiac output value by the thermodilution method or the cardiac output input means 150.
Is stored as the cardiac output during calibration, and the blood temperature signal from the blood temperature measurement circuit 125 and the equilibrium temperature signal from the equilibrium temperature measurement circuit 126 are respectively calibrated. The blood temperature and the equilibrium temperature during calibration are retained and stored. Then, when there is a request from the continuous cardiac output calculation means 143, the stored data is output.

【0036】連続心拍出量演算手段143は、前記校正
時信号記憶手段142が記憶保持している校正時心拍出
量、校正時血液温度、校正時平衡温度、並びに計測時の
血液温度、計測時の平衡温度とから、以下の[5]式に
基づいて連続心拍出量を演算する。
The continuous cardiac output calculating means 143 calculates the cardiac output at the time of calibration, the blood temperature at the time of calibration, the equilibrium temperature at the time of calibration, and the blood temperature at the time of measurement, which are stored and held by the signal storage means 142 at the time of calibration. Based on the equilibrium temperature at the time of measurement, the continuous cardiac output is calculated based on the following equation [5].

【0037】 CO=COCAL ×((TtR −K・(TB −TBCAL)) / TtCAL)1/A …[5] ここで、CO:心拍出量、COCAL:校正時の心拍出量T
R:計測時の平衡温度、TB: 血液温度TBCAL:校正時
の血液温度、K: 温度補正定数TtCAL:校正時の平衡温
度、A: 定数である。
CO = CO CAL × ((Tt R− K · (TB−TB CAL )) / Tt CAL ) 1 / A (5) where CO: cardiac output, CO CAL : heart at the time of calibration Output T
t R : equilibrium temperature at measurement, TB: blood temperature TB CAL : blood temperature at calibration, K: temperature correction constant Tt CAL : equilibrium temperature at calibration, A: constant.

【0038】上記[5]式より、校正時からの血液温度
変化に伴う平衡温度変化の補正も成されていることがわ
かる。従つて、血流速の絶対値を計測しなくても、連続
的に高精度な心拍出量の測定が可能となる。
From the above equation [5], it can be seen that the correction of the equilibrium temperature change accompanying the blood temperature change from the time of calibration is also performed. Therefore, it is possible to continuously measure the cardiac output with high accuracy without measuring the absolute value of the blood flow velocity.

【0039】以上の構成において、計測時並びに校正時
の中枢部の体温(肺動脈中での血液温度)、加温が行な
われ血流により冷却され平衡状態に達したときの平衡温
度、及び心拍出量が得られ、血流速の変化を温度変化と
して検出しその温度変化情報から直接心拍出量の変化を
求め、実験的にプローブ出力に合わせた関数、パラメー
タによつて演算することにより、血流速の絶対値を計測
せずに連続的に心拍出量の測定が行なえるようにしたも
のである。
In the above configuration, the body temperature (blood temperature in the pulmonary artery) at the central part at the time of measurement and calibration, the equilibrium temperature at the time of heating and cooling by the blood flow to reach an equilibrium state, and the heart rate The output is obtained, the change in blood flow velocity is detected as a temperature change, the change in cardiac output is directly obtained from the temperature change information, and it is calculated experimentally using functions and parameters that match the probe output. In addition, the cardiac output can be continuously measured without measuring the absolute value of the blood flow velocity.

【0040】<酸素飽和度モニタ部の構成例>図4は酸
素飽和度モニタ部の一構成例を示すブロツク図である。
<Example of the Configuration of the Oxygen Saturation Monitor> FIG. 4 is a block diagram showing an example of the configuration of the oxygen saturation monitor.

【0041】図において、211は肺動脈等に留置され
血液中での光の反射光強度を測定するためのカテーテル
である。212はパルスタイミング回路で、LED駆動
回路213にLED214(241と242)の駆動タ
イミング信号を出力するとともに、各LEDより発光さ
れる波長の異なる光よりの反射光強度をサンプリングす
るためのタイミング信号をサンプル・ホールド回路21
8に出力している。213はLED駆動回路で、パルス
タイミング回路212よりのタイミング信号により、L
ED214の2つのLED241と242のいずれかを
駆動して発光させている。214は660nmの波長の
光と805nmの波長の光とを出力することができる発
光ダイオード(LED)で、ここではLED241( 波
長が660nm ) とLED242( 波長が805nm)の2つで構
成している。こうして各LEDから発せられる波長の異
なる光は、光カプラで結合されて1本の光フアイバにま
とめられ、カテーテル211に送られる。
In the figure, reference numeral 211 denotes a catheter which is indwelled in a pulmonary artery or the like and measures the reflected light intensity of light in blood. A pulse timing circuit 212 outputs a drive timing signal of the LEDs 214 (241 and 242) to the LED drive circuit 213, and outputs a timing signal for sampling the intensity of reflected light from light of different wavelengths emitted from each LED. Sample and hold circuit 21
8 is output. Reference numeral 213 denotes an LED driving circuit, which is driven by a timing signal from the pulse timing
One of the two LEDs 241 and 242 of the ED 214 is driven to emit light. Reference numeral 214 denotes a light-emitting diode (LED) capable of outputting light having a wavelength of 660 nm and light having a wavelength of 805 nm. In this example, the light-emitting diode 214 includes an LED 241 (having a wavelength of 660 nm) and an LED 242 (having a wavelength of 805 nm). . In this manner, the light of different wavelengths emitted from each LED is combined by an optical coupler, collected into one optical fiber, and sent to the catheter 211.

【0042】なお、LED214を、例えば駆動電圧な
どを変化させることによりその出力光の波長を660n
mと805nmとの間で変更できるLEDとすると、1
つのLEDで代用できる。
The wavelength of the output light of the LED 214 is changed to 660 n by changing the drive voltage or the like.
Assuming that the LED can be changed between m and 805 nm, 1
One LED can be substituted.

【0043】215はカテーテル211と酸素飽和度モ
ニタ部本体とを接続する接続部で、カテーテル211と
本体とは光ケーブル228で接続されている。216は
光電変換部とプリアンプとが一体化された部分で、カテ
ーテル211よりの反射光を入力して、その入力光の強
度に対応した電気信号を出力している。217はメイン
アンプで、光電変換部216よりの電気信号を更に増幅
している。サンプルホールド回路218は、パルスタイ
ミング回路212よりのタイミング信号を入力し、その
タイミング信号に同期してメインアンプ部217よりの
アナログ信号をサンプルホールドする。
A connection portion 215 connects the catheter 211 and the oxygen saturation monitor main body, and the catheter 211 and the main body are connected by an optical cable 228. Reference numeral 216 denotes a portion where the photoelectric conversion unit and the preamplifier are integrated, and inputs reflected light from the catheter 211 and outputs an electric signal corresponding to the intensity of the input light. A main amplifier 217 further amplifies the electric signal from the photoelectric conversion unit 216. The sample hold circuit 218 receives the timing signal from the pulse timing circuit 212, and samples and holds the analog signal from the main amplifier 217 in synchronization with the timing signal.

【0044】なお、LED214より発光される各波長
の光は、互いに時間的な重なりが生じないようにパルス
タイミング回路212よりのタイミング信号で制御され
ているため、サンプルホールド回路218では各波長に
対する反射光強度を独立してホールドすることができ
る。こうしてサンプルホールドされた信号は、フイルタ
回路219によりノイズ成分がフイルタリングされた
後、制御部32に出力される。
Since the light of each wavelength emitted from the LED 214 is controlled by the timing signal from the pulse timing circuit 212 so as not to overlap with each other in time, the sample and hold circuit 218 reflects the light for each wavelength. Light intensity can be held independently. The signal thus sampled and held is output to the control unit 32 after the noise component is filtered by the filter circuit 219.

【0045】制御部32では、フイルタ回路219より
のアナログ信号をA/Dコンバータ222によりデジタ
ル信号に変換してCPU回路221に入力している。制
御部32はパルスタイミング回路212よりのタイミン
グ信号233,234を入力しており、これによりA/
Dコンバータ222より入力したデジタル信号が、いず
れよりのどの波長に対する反射光強度であるかを判別す
ることができる。ここでは、例えばタイミング信号23
3は波長が660nmの光に対する反射光強度の入力タ
イミングを示し、タイミング信号234は波長805n
mの光に対する反射光強度の入力タイミングを示してい
る。
In the control section 32, the analog signal from the filter circuit 219 is converted into a digital signal by the A / D converter 222 and input to the CPU circuit 221. The control unit 32 receives the timing signals 233 and 234 from the pulse timing circuit 212, and
It is possible to determine which one of the digital signals input from the D converter 222 has the reflected light intensity for which wavelength. Here, for example, the timing signal 23
3 indicates the input timing of the reflected light intensity for the light having the wavelength of 660 nm, and the timing signal 234 indicates the wavelength 805n.
The input timing of the reflected light intensity for the light of m is shown.

【0046】221はマイクロプロセツサなどを含むC
PU回路で、ROM224に記憶されている制御プログ
ラムや各種データに従つて制御を行つている。225は
CPU回路のワークエリアとして使用され、各種データ
を一時保存するRAMである。228は、例えば外部出
力端子を通して接続されている外部装置に測定データな
どを出力するための外部出力回路である。
Reference numeral 221 denotes a C including a microprocessor or the like.
The PU circuit controls according to a control program and various data stored in the ROM 224. A RAM 225 is used as a work area of the CPU circuit and temporarily stores various data. An external output circuit 228 outputs, for example, measurement data to an external device connected through an external output terminal.

【0047】酸素と結合していないヘモグロビンの吸光
特性と酸素と結合しているヘモグロビンの吸光特性との
差が大きくなるときと、これら2つの特性の差が“0”
になるときとに、それぞれに対応する波長は660n
m,805nmとなつている。従つて、これら2つの波
長のそれぞれを血液中に照射し、その反射光を検出し
て、その比を取ることにより、血液中の酸素飽和度を求
めることができる。
When the difference between the absorption characteristics of hemoglobin not bound to oxygen and the absorption characteristics of hemoglobin bound to oxygen increases, the difference between these two characteristics is “0”.
And the corresponding wavelength is 660n
m, 805 nm. Therefore, the blood is irradiated with each of these two wavelengths, the reflected light is detected, and the ratio between the two is obtained, whereby the oxygen saturation in the blood can be obtained.

【0048】<プローブの構成例>図5はプローブ50
の構成例を示す図である。本プローブは、心拍出量測定
用カテーテル107と、酸素飽和度モニタ用カテーテル
211とを1つにまとめて含むもので、光照射用の光フ
アイバや血液中で反射されて入射される光を取り入れる
ための光入射用の光フアイバ等を一体化したものであ
る。このプローブ50は、例えば肺動脈等に挿入され
て、連続的に心拍出量及び血液の酸素飽和度が測定され
る。
<Example of Probe Configuration> FIG.
FIG. 3 is a diagram showing an example of the configuration of FIG. This probe includes the cardiac output measuring catheter 107 and the oxygen saturation monitoring catheter 211 as one unit. The probe reflects light incident on the optical fiber for light irradiation or reflected in blood. It integrates an optical fiber for light incidence for taking in. The probe 50 is inserted into, for example, a pulmonary artery or the like, and continuously measures cardiac output and blood oxygen saturation.

【0049】[0049]

【発明の効果】本発明により、酸素の需給バランスをよ
り確実に把握でき、術中,術後の患者管理に有用な患者
監視システムを提供できる。
According to the present invention, it is possible to provide a patient monitoring system which can more reliably grasp the supply and demand balance of oxygen and is useful for intraoperative and postoperative patient management.

【0050】すなわち、連続的に酸素飽和度値と心拍出
量を単一のプローブでモニタできる。また、混合静脈血
酸素飽和度(SvO2 )と心拍出量の連続情報と、ヘモ
グロビン濃度および動脈血酸素飽和度の入力情報とから
酸素消費量を連続的に算出できる。さらに、パルスオキ
シメータ等から動脈血酸素飽和度を連続的に入力するこ
とにより、酸素消費量をより正確にモニタでき、また酸
素摂取率も算出できる。
That is, the oxygen saturation value and the cardiac output can be continuously monitored with a single probe. Further, the oxygen consumption can be continuously calculated from the continuous information of the mixed venous oxygen saturation (SvO 2 ) and the cardiac output, and the input information of the hemoglobin concentration and the arterial oxygen saturation. Further, by continuously inputting the arterial blood oxygen saturation from a pulse oximeter or the like, the oxygen consumption can be monitored more accurately and the oxygen intake rate can be calculated.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本実施例の患者監視システムの構成を示すブロ
ック図である。
FIG. 1 is a block diagram illustrating a configuration of a patient monitoring system according to an embodiment.

【図2】メインCPU回路の制御手順を示すフローチヤ
ートである。
FIG. 2 is a flowchart showing a control procedure of a main CPU circuit.

【図3】心拍出量モニタ部の一構成例のブロツク図であ
る。
FIG. 3 is a block diagram of a configuration example of a cardiac output monitor section.

【図4】酸素飽和度モニタ部の一構成例を示すブロツク
図である。
FIG. 4 is a block diagram showing one configuration example of an oxygen saturation monitor.

【図5】プローブの構成例を示す図である。FIG. 5 is a diagram showing a configuration example of a probe.

【符合の説明】[Description of sign]

10…酸素消費量演算部、20…心拍出量モニタ部、3
0…酸素飽和度モニタ部、40…電源部、50…プロー
10: oxygen consumption calculation unit, 20: cardiac output monitor unit, 3
0: oxygen saturation monitoring section, 40: power supply section, 50: probe

フロントページの続き (56)参考文献 特開 平2−134132(JP,A) 特開 平2−111343(JP,A) 特開 平2−13450(JP,A) 特開 昭64−11531(JP,A) 特開 平1−146524(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61B 5/145 A61B 5/00 102 A61B 5/0205 Continuation of the front page (56) References JP-A-2-134132 (JP, A) JP-A-2-111343 (JP, A) JP-A-2-13450 (JP, A) JP-A 64-11531 (JP) , A) JP-A-1-146524 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61B 5/145 A61B 5/00 102 A61B 5/0205

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 混合静脈血の酸素飽和度値を連続的に測
定する酸素飽和度測定手段と、 連続的に心拍出量を測定する心拍出量測定手段と、 動脈血酸素飽和度値とヘモグロビン濃度とを入力するパ
ラメータ入力手段と、 前記酸素飽和度測定手段により求められた混合静脈血の
前記酸素飽和度値と、前記心拍出量測定手段により求め
られた前記心拍出量値と、前記パラメータ入力手段によ
り入力された前記動脈血酸素飽和度値及びヘモグロビン
濃度とから連続的に酸素消費量を算出する酸素消費量算
出手段とを備えることを特徴とする患者監視システム。
1. An oxygen saturation measuring means for continuously measuring the oxygen saturation value of mixed venous blood, a cardiac output measuring means for continuously measuring cardiac output, and an arterial oxygen saturation value. Parameter input means for inputting the hemoglobin concentration, the oxygen saturation value of the mixed venous blood determined by the oxygen saturation measurement means, and the cardiac output value determined by the cardiac output measurement means An oxygen consumption calculating means for continuously calculating oxygen consumption from the arterial blood oxygen saturation value and the hemoglobin concentration input by the parameter input means.
【請求項2】 前記酸素飽和度測定手段により求められ
た混合静脈血の前記酸素飽和度値と、前記パラメータ入
力手段により入力された前記動脈血酸素飽和度値とから
連続的に酸素摂取率を算出する酸素摂取率算出手段を更
に備えることを特徴とする請求項1記載の患者監視シス
テム。
2. An oxygen uptake rate is continuously calculated from the oxygen saturation value of the mixed venous blood obtained by the oxygen saturation measurement means and the arterial blood oxygen saturation value inputted by the parameter input means. 2. The patient monitoring system according to claim 1, further comprising: an oxygen intake rate calculating unit that performs the calculation.
【請求項3】 酸素飽和度測定手段は2つの異なる波長
の光の血液への照射に対する反射光強度の比に基づいて
連続的に血液の酸素飽和度を測定することを特徴とする
請求項1記載の患者監視システム。
3. The oxygen saturation measuring means according to claim 1, wherein the oxygen saturation measuring means continuously measures the oxygen saturation of the blood based on the ratio of the intensity of the reflected light with respect to the irradiation of the blood with light of two different wavelengths. A patient monitoring system as described.
【請求項4】 心拍出量測定手段は校正時の血液温度,
血流速に依存する平衡温度及び熱希釈法により求めた心
拍出量に基づいて、測定時の血液温度と血流速に依存す
る平衡温度とから連続的に心拍出量を測定することを特
徴とする請求項1記載の患者監視システム。
4. The cardiac output measuring means includes a blood temperature at the time of calibration,
To continuously measure the cardiac output from the blood temperature at the time of measurement and the equilibrium temperature depending on the blood flow rate, based on the equilibrium temperature depending on the blood flow rate and the cardiac output determined by the thermodilution method The patient monitoring system according to claim 1, wherein:
【請求項5】 前記酸素飽和度測定手段と前記心拍出量
測定手段とに必要な信号を検出して供給する単一のプロ
ーブを更に備えることを特徴とする請求項1記載の患者
監視システム。
5. The patient monitoring system according to claim 1, further comprising a single probe for detecting and supplying signals required for said oxygen saturation measuring means and said cardiac output measuring means. .
JP03264039A 1991-10-11 1991-10-11 Patient monitoring system Expired - Fee Related JP3115374B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03264039A JP3115374B2 (en) 1991-10-11 1991-10-11 Patient monitoring system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03264039A JP3115374B2 (en) 1991-10-11 1991-10-11 Patient monitoring system

Publications (2)

Publication Number Publication Date
JPH0595939A JPH0595939A (en) 1993-04-20
JP3115374B2 true JP3115374B2 (en) 2000-12-04

Family

ID=17397704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03264039A Expired - Fee Related JP3115374B2 (en) 1991-10-11 1991-10-11 Patient monitoring system

Country Status (1)

Country Link
JP (1) JP3115374B2 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7647084B2 (en) 2005-08-08 2010-01-12 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7650177B2 (en) 2005-09-29 2010-01-19 Nellcor Puritan Bennett Llc Medical sensor for reducing motion artifacts and technique for using the same
US7657295B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7657296B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Unitary medical sensor assembly and technique for using the same
US7676253B2 (en) 2005-09-29 2010-03-09 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7684842B2 (en) 2006-09-29 2010-03-23 Nellcor Puritan Bennett Llc System and method for preventing sensor misuse
US7796403B2 (en) 2006-09-28 2010-09-14 Nellcor Puritan Bennett Llc Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit
US7869849B2 (en) 2006-09-26 2011-01-11 Nellcor Puritan Bennett Llc Opaque, electrically nonconductive region on a medical sensor
US7881762B2 (en) 2005-09-30 2011-02-01 Nellcor Puritan Bennett Llc Clip-style medical sensor and technique for using the same
US7894869B2 (en) 2007-03-09 2011-02-22 Nellcor Puritan Bennett Llc Multiple configuration medical sensor and technique for using the same
US7899510B2 (en) 2005-09-29 2011-03-01 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8073518B2 (en) 2006-05-02 2011-12-06 Nellcor Puritan Bennett Llc Clip-style medical sensor and technique for using the same
US8145288B2 (en) 2006-08-22 2012-03-27 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8175671B2 (en) 2006-09-22 2012-05-08 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8190224B2 (en) 2006-09-22 2012-05-29 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8219170B2 (en) 2006-09-20 2012-07-10 Nellcor Puritan Bennett Llc System and method for practicing spectrophotometry using light emitting nanostructure devices
US8265724B2 (en) 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
US8280469B2 (en) 2007-03-09 2012-10-02 Nellcor Puritan Bennett Llc Method for detection of aberrant tissue spectra
US8315685B2 (en) 2006-09-27 2012-11-20 Nellcor Puritan Bennett Llc Flexible medical sensor enclosure
US8346328B2 (en) 2007-12-21 2013-01-01 Covidien Lp Medical sensor and technique for using the same
US8352004B2 (en) 2007-12-21 2013-01-08 Covidien Lp Medical sensor and technique for using the same
US8352009B2 (en) 2005-09-30 2013-01-08 Covidien Lp Medical sensor and technique for using the same
US8386002B2 (en) 2005-09-30 2013-02-26 Covidien Lp Optically aligned pulse oximetry sensor and technique for using the same
US8396527B2 (en) 2006-09-22 2013-03-12 Covidien Lp Medical sensor for reducing signal artifacts and technique for using the same
US8649839B2 (en) 1996-10-10 2014-02-11 Covidien Lp Motion compatible sensor for non-invasive optical blood analysis
US8728059B2 (en) 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
US8880155B2 (en) 2012-02-24 2014-11-04 Covidien Lp Hypovolemia diagnosis technique

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113100758B (en) * 2021-04-15 2022-03-08 深圳市景新浩科技有限公司 Mobile internet-based health monitoring and management system for blood oxygen data of old people

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8649839B2 (en) 1996-10-10 2014-02-11 Covidien Lp Motion compatible sensor for non-invasive optical blood analysis
US7738937B2 (en) 2005-08-08 2010-06-15 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7647084B2 (en) 2005-08-08 2010-01-12 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7657294B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Compliant diaphragm medical sensor and technique for using the same
US7657295B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7657296B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Unitary medical sensor assembly and technique for using the same
US8311602B2 (en) 2005-08-08 2012-11-13 Nellcor Puritan Bennett Llc Compliant diaphragm medical sensor and technique for using the same
US7684843B2 (en) 2005-08-08 2010-03-23 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7693559B2 (en) 2005-08-08 2010-04-06 Nellcor Puritan Bennett Llc Medical sensor having a deformable region and technique for using the same
US7676253B2 (en) 2005-09-29 2010-03-09 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7729736B2 (en) 2005-09-29 2010-06-01 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7869850B2 (en) 2005-09-29 2011-01-11 Nellcor Puritan Bennett Llc Medical sensor for reducing motion artifacts and technique for using the same
US7899510B2 (en) 2005-09-29 2011-03-01 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7904130B2 (en) 2005-09-29 2011-03-08 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8060171B2 (en) 2005-09-29 2011-11-15 Nellcor Puritan Bennett Llc Medical sensor for reducing motion artifacts and technique for using the same
US7650177B2 (en) 2005-09-29 2010-01-19 Nellcor Puritan Bennett Llc Medical sensor for reducing motion artifacts and technique for using the same
US8386002B2 (en) 2005-09-30 2013-02-26 Covidien Lp Optically aligned pulse oximetry sensor and technique for using the same
US7881762B2 (en) 2005-09-30 2011-02-01 Nellcor Puritan Bennett Llc Clip-style medical sensor and technique for using the same
US8352009B2 (en) 2005-09-30 2013-01-08 Covidien Lp Medical sensor and technique for using the same
US8437826B2 (en) 2006-05-02 2013-05-07 Covidien Lp Clip-style medical sensor and technique for using the same
US8073518B2 (en) 2006-05-02 2011-12-06 Nellcor Puritan Bennett Llc Clip-style medical sensor and technique for using the same
US8145288B2 (en) 2006-08-22 2012-03-27 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8577436B2 (en) 2006-08-22 2013-11-05 Covidien Lp Medical sensor for reducing signal artifacts and technique for using the same
US8219170B2 (en) 2006-09-20 2012-07-10 Nellcor Puritan Bennett Llc System and method for practicing spectrophotometry using light emitting nanostructure devices
US8396527B2 (en) 2006-09-22 2013-03-12 Covidien Lp Medical sensor for reducing signal artifacts and technique for using the same
US8190225B2 (en) 2006-09-22 2012-05-29 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8195264B2 (en) 2006-09-22 2012-06-05 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8190224B2 (en) 2006-09-22 2012-05-29 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8175671B2 (en) 2006-09-22 2012-05-08 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US7869849B2 (en) 2006-09-26 2011-01-11 Nellcor Puritan Bennett Llc Opaque, electrically nonconductive region on a medical sensor
US8315685B2 (en) 2006-09-27 2012-11-20 Nellcor Puritan Bennett Llc Flexible medical sensor enclosure
US7796403B2 (en) 2006-09-28 2010-09-14 Nellcor Puritan Bennett Llc Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit
US8728059B2 (en) 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
US7684842B2 (en) 2006-09-29 2010-03-23 Nellcor Puritan Bennett Llc System and method for preventing sensor misuse
US8265724B2 (en) 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
US7894869B2 (en) 2007-03-09 2011-02-22 Nellcor Puritan Bennett Llc Multiple configuration medical sensor and technique for using the same
US8280469B2 (en) 2007-03-09 2012-10-02 Nellcor Puritan Bennett Llc Method for detection of aberrant tissue spectra
US8352004B2 (en) 2007-12-21 2013-01-08 Covidien Lp Medical sensor and technique for using the same
US8346328B2 (en) 2007-12-21 2013-01-01 Covidien Lp Medical sensor and technique for using the same
US8880155B2 (en) 2012-02-24 2014-11-04 Covidien Lp Hypovolemia diagnosis technique
US11478155B2 (en) 2012-02-24 2022-10-25 Covidien Lp Hypovolemia diagnosis technique

Also Published As

Publication number Publication date
JPH0595939A (en) 1993-04-20

Similar Documents

Publication Publication Date Title
JP3115374B2 (en) Patient monitoring system
EP0850013B1 (en) Procedure for the determination of fractional oxygen saturation
US5069214A (en) Flash reflectance oximeter
US9788768B2 (en) Physiological parameter tracking system
US7438683B2 (en) Application identification sensor
JP5009309B2 (en) Sensor system with memory and method of using the sensor
JP3837161B2 (en) Light source with tunable wavelength for oximeter
US5685301A (en) Apparatus for precise determination of operating characteristics of optical devices contained in a monitoring probe
JP4038280B2 (en) Non-invasive biological component measuring device
JPH02128753A (en) Apparatus for measuring cardiac output
US6097975A (en) Apparatus and method for noninvasive glucose measurement
DK0652727T3 (en) Universal heart catheter for measuring multiple parameters
US20030050545A1 (en) Diode detection circuit
US10278622B2 (en) Device for non-invasive measurement of blood sugar level
JPH0417051B2 (en)
JPH02185232A (en) Bio-information measuring device
JPH10328170A (en) Blood sugar monitoring system
EP1629766A1 (en) Blood sugar level measuring apparatus
JP3815119B2 (en) Biological signal detector
US11883168B2 (en) Oxygen saturation measuring device, probe adapted to be used therefor, and oxygen saturation measuring method
JP2000107157A (en) Device for measuring oxygen saturation
JP2932644B2 (en) Method and apparatus for measuring cytochrome oxidase
CN219183764U (en) Blood glucose detecting system and blood glucose meter based on laser reflection
EP3939505A1 (en) Device for obtaining an indicator of a microcirculatory condition
CN220275597U (en) Blood glucose detecting system and blood glucose meter based on laser transmission type

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20000828

LAPS Cancellation because of no payment of annual fees